Evidence map›Paper›PMID 40496777›Full record

ReviewPublic health challenges2023

Global health trends of human papillomavirus-associated oral cancer: A review.

Kehinde Kazeem Kanmodi, Jimoh Amzat, Jacob Njideka Nwafor, Lawrence Achilles Nnyanzi

Abstract readReview
In one paragraph

Review in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kehinde Kazeem KanmodiFaculty of Dentistry University of Puthisastra Phnom Penh Cambodia.ORCID https://orcid.org/0000-0001-9906-3826
Jimoh AmzatDepartment of Sociology Usmanu Danfodiyo University Sokoto Nigeria.
Jacob Njideka NwaforCampaign for Head and Neck Cancer Education (CHANCE) Programme Cephas Health Research Initiative Inc Ibadan Nigeria.
Lawrence Achilles NnyanziSchool of Health and Life Sciences Teesside University Middlesbrough UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral cancer is a malignant neoplastic disease, it constitutes the most common cancer in the head-and-neck region, and it is the 16th most common and 15th deadliest cancer type affecting humans. Despite the global efforts channelled towards global cancer control, the burden of oral cancer is still increasing. Every year, several thousands of people across 195 countries/territories die of oral cancer, and only about 40%-50% of the victims of oral cancer barely survive for 5 years after diagnosis. Within the past few decades, there has been a paradigm shift in the epidemiological trend of oral cancer risk factors. Oral sex - a major route of transmission of human papillomavirus (HPV) - was found to be increasing at an alarming rate, whereas tobacco and alcohol use had been on the decline. This narrative review critically discussed the contemporary challenges facing the global eradication of HPV-associated oral cancer, with reasonable recommendations. The challenges discussed in this review are major, ranging from clinical to public health policy issues, which include the lack of validated and inexpensive oral HPV screening and diagnostic tools, high global public illiteracy on oral HPV infection, diverse sociocultural factors, weak global research capacity on oral HPV infection and HPV-associated oral cancer and the absence of policies across different countries on national preventive programmes on HPV-associated oral cancer. This review also identified the need for more attention towards the prevention and control oral HPV infection and HPV-associated oral cancers globally.

Indexed as

challengescontrolglobal healthhuman papillomavirusoral cancerrecommendations

Identifiers

PMID40496777
PMCPMC12039698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.